News about "clinical study"

PharmaJet, REDE-TB to Launch Clinical Study on Needle-Free TB Skin Testing Technology

PharmaJet, REDE-TB to Launch Clinical Study on Needle-Free TB Skin Testing Technology

The study will evaluate accuracy, safety and patient acceptance of needle-free Tropis system compared to traditional tuberculin skin test

Clinical Study | 26/03/2026 | By News Bureau

US Food and Drug Administration to Drop Two-Study Requirement for New Drug Approvals

US Food and Drug Administration to Drop Two-Study Requirement for New Drug Approvals

The US Food and Drug Administration has announced plans to eliminate its long-standing expectation that new medicines be supported by at least two pivotal clinical trials, signaling a significant shift in regulatory policy aimed at accelerating patient access to innovative therapies.

Clinical Study | 19/02/2026 | By Darshana 127

Thryv Therapeutics Initiates Wave II Phase II/III Trial for Long QT Syndrome Type 2

Thryv Therapeutics Initiates Wave II Phase II/III Trial for Long QT Syndrome Type 2

Thryv Therapeutics has launched the Wave II Phase II/III trial to evaluate THRV-1268, an oral SGK1 inhibitor, as a potential disease-modifying therapy for adults with Long QT Syndrome Type 2.

Clinical Study | 14/01/2026 | By News Bureau 123

Mercy Joins REACH Study to Evaluate GRAIL Galleri Test in Medicare Population

Mercy Joins REACH Study to Evaluate GRAIL Galleri Test in Medicare Population

The three year clinical study will assess real-world impact of multi-cancer early detection testing among up to 50,000 Medicare beneficiaries.

Clinical Study | 09/01/2026 | By News Bureau 147

NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004

NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004

NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.

Clinical Study | 22/03/2024 | By Manvi 436

Anti-Tigit drug of Roche fails stage study

Anti-Tigit drug of Roche fails stage study

Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.

Clinical Study | 26/04/2022 | By Sudeep Soparkar 807


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members